
Spirit Airlines announced Wednesday that it has postponed a Friday meeting in which shareholders were slated to vote on a plan to merge with Frontier Airlines. The meeting was moved to June 30.
The announcement comes two days after JetBlue Airways, which has its own plan to acquire Spirit, sweetened its offer for the carrier by $150 million, saying it would pay Spirit $350 million in the “unlikely” event that a merger between the two carriers failed to win regulatory approval. A portion of that reverse breakup fee would include a cash payment to shareholders.
That revised proposal came after Frontier said last week that it would offer a $250 million reverse breakup fee if its proposed deal with Spirit wasn’t approved by regulators.
Spirit said the delay will give its board of directors time to continue discussions with Spirit shareholders, as well as with Frontier and JetBlue.
“I know this delay may be frustrating, I’m sure you were eager to hear the results of the shareholder vote and have a better idea of what lies ahead,” Spirit chief executive Ted Christie wrote in a note to employees Wednesday. “Let me reassure you as we go through this process, we remain focused on the well-being of our Spirit family.”
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas